- HALO platform for image analysis at scale
- Targets pathology needs rather than a generic suite
- Scales to organization-wide healthcare rollouts
Indica Labs
HALO digital pathology image analysis platform
SF7.6
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Route cases for specialty reviewPathology labs and pharma research
Route cases for specialty reviewPathology labs and pharma research
Best for
Pathology labs and pharma research
Pricing
Custom
SoftFinders Score
7.6 / 10
Overview
What is Indica Labs?
Indica Labs is a digital pathology company offering the HALO platform for image management and quantitative tissue analysis. The product is positioned around digital slide workflow, image analysis, and case prioritization rather than autonomous diagnosis, and pathologist review of every flagged case remains essential for clinical sign-off. Buyers should confirm lab information system integration depth, slide scanner compatibility, and validation evidence for the specific tissue types under review.
Indica Labs works best for pathology labs and pharma research, and its edge is HALO platform for image analysis at scale. The honest trade-off here: best value needs digital pathology investment. Pricing is sales-led and scoped per buyer rather than posted publicly. Run a small pilot to confirm fit before committing to a wider rollout.
KEY FEATURES
What you get out of the box
Biomarker Tools
Tools to explore quantitative biomarkers
Workflow Routing
Routes cases through pathology lab steps
Lab Integration
Connects with lab information systems
Quality Review
Supports quality control across cases
Research Modules
Modules for translational research workflows
Case Sharing
Shares cases across teams for second review
USE CASES
Where teams put it to work
Route cases for specialty review
Prioritize complex pathology cases
Bridge pathology labs and biopharma
Support image analysis for cancer cases
Enable telepathology consult workflows
Manage digital pathology slides centrally
Editorial Take
What we like, and what to verify
- Best value needs digital pathology investment
- Pathologist sign-off required on every case
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Ibex Medical Analytics SF 7.8
Why consider it
AI cancer detection for biopsy slides
Visiopharm SF 7.5
Why consider it
Quantitative digital pathology image analysis
OptraHEALTH SF 6.8
Why consider it
AI for pathology and genomics knowledge
Aiforia SF 7.4
Why consider it
Cloud deep learning for tissue analysis
Mindpeak SF 7.2
Why consider it
Consistency-focused AI tumor analysis tools
PreciseDx SF 7
Why consider it
Quantitative AI cancer grading and risk
FAQ